Avenue Therapeutics (ATXI) Short Interest Ratio & Short Volume $0.21 -0.08 (-26.59%) As of 02:00 PM Eastern Add Compare Share Share Short Interest Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Avenue Therapeutics Short Interest DataAvenue Therapeutics (ATXI) has a short interest of 55,600 shares, representing 2.76% of the float (the number of shares available for trading by the public). This marks a -5.44% decrease in short interest from the previous month. The short interest ratio (days to cover) is 10.3, indicating that it would take 10.3 days of the average trading volume of 131,179 shares to cover all short positions.Current Short Interest55,600 sharesPrevious Short Interest58,800 sharesChange Vs. Previous Month-5.44%Dollar Volume Sold Short$12.12 thousandShort Interest Ratio10.3 Days to CoverLast Record DateMay 31, 2025Outstanding Shares3,183,000 sharesShort Percent of Float2.76%Today's Trading Volume2,392 sharesAverage Trading Volume131,179 sharesToday's Volume Vs. Average2% Short Selling Avenue Therapeutics? Sign up to receive the latest short interest report for Avenue Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartATXI Short Interest Over TimeATXI Days to Cover Over TimeATXI Percentage of Float Shorted Over Time Avenue Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 5/31/202555,600 shares $12.12 thousand -5.4%2.8%10.3 $0.22 5/15/202558,800 shares $14.70 thousand -11.8%N/A5.5 $0.25 4/30/202566,700 shares $16.06 thousand -2.2%N/A4.3 $0.24 4/15/202568,200 shares $17.96 thousand -12.1%N/A2.5 $0.26 3/15/202551,400 shares $43.59 thousand -13.9%3.0%0.1 $0.85 2/28/202559,700 shares $65.67 thousand -35.3%3.4%0.2 $1.10 2/15/202592,200 shares $125.39 thousand -40.5%5.3%0.2 $1.36 1/31/2025154,900 shares $210.66 thousand +92.2%8.9%0.4 $1.36 1/15/202580,600 shares $153.14 thousand +258.2%4.6%0.2 $1.90 12/31/202422,500 shares $45 thousand -35.9%1.3%0.5 $2.00 Get the Latest News and Ratings for ATXI and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Avenue Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 12/15/202435,100 shares $63.18 thousand -25.0%1.9%0.8 $1.80 11/30/202446,800 shares $100.43 thousand +6.1%2.7%1.1 $2.15 11/15/202444,100 shares $85.11 thousand -13.4%2.4%1 $1.93 10/31/202450,900 shares $123.18 thousand +85.8%3.7%1.1 $2.42 10/15/202427,400 shares $57.27 thousand -13.0%2.0%0.5 $2.09 9/30/202431,500 shares $78.44 thousand +107.2%2.3%0.7 $2.49 9/15/202415,200 shares $42.71 thousand -58.6%1.1%0.3 $2.81 8/31/202436,700 shares $93.22 thousand -22.3%2.8%0.8 $2.54 8/15/202447,200 shares $121.97 thousand -5.0%3.6%1 $2.58 7/31/202449,700 shares $139.16 thousand +21.8%5.7%1 $2.80 7/15/202440,800 shares $141.58 thousand +3.8%4.7%0.6 $3.47 6/30/202439,300 shares $137.55 thousand -7.3%4.5%0.6 $3.50 6/15/202442,400 shares $157.30 thousand -14.3%4.9%0.7 $3.71 5/31/202449,500 shares $170.28 thousand +7.4%6.0%0.8 $3.44 5/15/202446,100 shares $168.27 thousand +169.6%5.6%0.7 $3.65 4/30/202417,100 shares $85.67 thousand -91.2%3.3%0.3 $5.01 4/15/2024193,600 shares $24.20 thousand -31.6%N/A0.1 $0.13 3/31/2024283,100 shares $41.76 thousand -9.7%N/A0.1 $0.15 3/15/2024313,400 shares $49.36 thousand +91.7%N/A0.1 $0.16 2/29/2024163,500 shares $24.80 thousand -51.6%N/A0 $0.15 2/15/2024337,700 shares $49.74 thousand -50.1%N/A0.1 $0.15 1/31/2024677,300 shares $100.24 thousand -39.0%N/A0.1 $0.15 1/15/20241,110,000 shares $193.14 thousand +378.9%N/A0.2 $0.17 12/31/2023231,800 shares $37.32 thousand +1.2%3.1%0 $0.16 12/15/2023229,100 shares $33.91 thousand -65.6%2.4%0.1 $0.15 11/30/2023665,300 shares $141.04 thousand +329.8%9.2%0.4 $0.21 11/15/2023154,800 shares $28.73 thousand -69.9%1.6%0.8 $0.19 10/31/2023513,700 shares $120.72 thousand +39.0%7.7%3.3 $0.24 10/15/2023369,700 shares $221.75 thousand +73.2%5.6%5.7 $0.60 9/30/2023213,400 shares $150.87 thousand +699.3%3.3%2.9 $0.71Banks aren’t ready for this altcoin—are you? (Ad)While everyone's distracted by Bitcoin's moves, a stealth revolution is underway. One altcoin is quietly positioning itself to overthrow the entire banking system.Click here to access the full report now. 9/15/202326,700 shares $22.13 thousand +184.0%0.5%0.4 $0.83 8/31/20239,400 shares $7.29 thousand -69.9%0.1%0.2 $0.78 8/15/202331,200 shares $31.20 thousand -47.7%0.5%0.5 $1.00 7/31/202359,600 shares $62.58 thousand -12.2%0.9%0.8 $1.05 7/15/202367,900 shares $81.28 thousand -45.9%1.1%0.7 $1.20 6/30/2023125,400 shares $144.21 thousand -4.7%2.0%0.6 $1.15 6/15/2023131,600 shares $152.66 thousand -32.7%2.1%0.5 $1.16 5/31/2023195,500 shares $211.14 thousand -35.0%3.3%0.5 $1.08 5/15/2023300,700 shares $321.75 thousand -16.3%5.1%0.6 $1.07 4/30/2023359,100 shares $341.11 thousand +49.8%5.2%0.7 $0.95 4/15/2023239,700 shares $261.27 thousand -16.6%3.9%0.4 $1.09 3/31/2023287,300 shares $334.70 thousand -36.7%4.8%0.3 $1.17 3/15/2023453,900 shares $531.06 thousand +208.8%7.5%0.5 $1.17 2/28/2023147,000 shares $163.17 thousand -10.7%2.4%0.2 $1.11 2/15/2023164,600 shares $204.10 thousand -42.8%2.7%0.2 $1.24 1/31/2023287,500 shares $396.75 thousand +229.0%6.6%0.3 $1.38 1/15/202387,400 shares $106.63 thousand -16.4%2.1%0.1 $1.22 12/30/2022104,500 shares $121.22 thousand -17.1%2.4%0 $1.16 12/15/2022126,100 shares $156.36 thousand -8.5%2.8%0 $1.24 11/30/2022137,800 shares $184.65 thousand +66.2%3.1%0 $1.34 11/15/202282,900 shares $137.61 thousand -61.0%1.9%0 $1.66 10/31/2022212,600 shares $508.11 thousand +1,463.2%5.6%0.1 $2.39 10/15/202213,600 shares $45.29 thousand -97.4%0.4%0 $3.33 9/30/2022524,700 shares $5.29 million +1,836.2%69.5%0.2 $10.08 9/15/202227,100 shares $108.54 thousand -82.1%N/A0.1 $4.01 8/31/2022151,200 shares $36.41 thousand +91.4%1.3%0.5 $0.24 8/15/202279,000 shares $23.09 thousand +28.5%0.7%0.3 $0.29 7/31/202261,500 shares $15.77 thousand +104.3%0.5%0.2 $0.26 7/15/202230,100 shares $8.03 thousand -61.2%0.3%0.1 $0.27 6/30/202277,600 shares $20.90 thousand -17.5%0.7%0.2 $0.27 6/15/202294,000 shares $25.19 thousand +50.9%0.8%0.3 $0.27 5/31/202262,300 shares $17.44 thousand -31.9%0.6%0.1 $0.28 5/15/202291,500 shares $30.93 thousand +10.5%0.8%0 $0.34 4/30/202282,800 shares $30.61 thousand +212.5%0.8%0 $0.37 4/15/202226,500 shares $12.73 thousand +108.7%0.2%0 $0.48 3/31/202212,700 shares $6.12 thousand -98.1%0.1%0 $0.48 3/15/2022674,600 shares $467.50 thousand +177.6%6.7%0.1 $0.69 2/28/2022243,000 shares $82.60 thousand +2.3%2.4%0.1 $0.34 2/15/2022237,600 shares $144.94 thousand -43.0%2.4%0.4 $0.61 1/31/2022416,900 shares $304.75 thousand -15.0%4.1%0.8 $0.73 1/15/2022490,300 shares $431.46 thousand -3.0%5.4%1 $0.88 12/31/2021505,600 shares $459.08 thousand -23.7%6.2%1 $0.91 12/15/2021662,500 shares $602.88 thousand +515.7%8.1%1.4 $0.91 11/30/2021107,600 shares $151.72 thousand -20.2%1.2%0.3 $1.41 11/15/2021134,800 shares $184.68 thousand -50.2%1.8%1.3 $1.37 10/29/2021270,500 shares $427.39 thousand +21.1%4.1%4.2 $1.58 10/15/2021223,300 shares $283.59 thousand -10.8%3.4%3.4 $1.27 9/30/2021250,200 shares $372.80 thousand -10.1%3.8%3 $1.49 9/15/2021278,400 shares $462.14 thousand -1.7%4.2%2 $1.66 8/31/2021283,300 shares $512.77 thousand +6.7%4.3%1 $1.81The Trump Dump is starting; Get out of stocks now? (Ad)The first 365 days of the Trump presidency… Will be the best time to get rich in American history.If I’m right about this (like I was before) a modest $900 investment could grow to a life-changing a 8/13/2021265,400 shares $453.83 thousand -13.8%4.0%0.9 $1.71 7/30/2021308,000 shares $551.32 thousand -27.0%4.7%1 $1.79 7/15/2021421,800 shares $873.13 thousand +17.8%6.4%1.3 $2.07 6/30/2021358,100 shares $898.83 thousand -28.0%5.4%0.9 $2.51 6/15/2021497,000 shares $1.39 million -4.5%7.5%1.2 $2.80 5/28/2021520,500 shares $2.58 million -2.3%7.9%1.8 $4.96 5/14/2021532,500 shares $2.22 million -13.8%8.0%1.6 $4.16 4/30/2021617,400 shares $3.24 million 0.0%9.3%1.8 $5.24 4/15/2021617,500 shares $2.95 million +37.6%9.3%2 $4.77 3/31/2021448,700 shares $2.58 million +11.5%6.8%1.8 $5.75 3/15/2021402,500 shares $2.75 million +12.8%6.1%1.5 $6.84 2/26/2021357,000 shares $1.76 million -6.9%5.4%0.9 $4.94 2/12/2021383,600 shares $2.62 million -17.9%5.8%1 $6.83 1/29/2021467,000 shares $2.81 million -11.2%7.0%1.2 $6.01 1/15/2021526,000 shares $3.31 million -12.4%7.9%1.4 $6.30 12/31/2020600,600 shares $3.48 million +73.7%9.0%1.1 $5.80 12/15/2020345,800 shares $1.25 million +13.0%5.2%0.6 $3.62 11/30/2020306,100 shares $1.04 million -7.2%4.6%1 $3.41 11/15/2020329,900 shares $1.09 million +9.8%5.0%1.2 $3.29 10/30/2020300,500 shares $955.59 thousand +4.1%4.5%1.1 $3.18 10/15/2020288,800 shares $1.15 million +110.7%4.4%1.2 $3.98 9/30/2020137,100 shares $1.48 million -8.1%2.1%3 $10.83 9/15/2020149,200 shares $1.78 million +0.8%2.3%2.9 $11.96 8/31/2020148,000 shares $1.65 million -13.7%2.2%3.1 $11.13 8/14/2020171,400 shares $1.82 million -34.4%2.6%3.2 $10.59 7/31/2020261,200 shares $2.65 million +13.6%4.0%4.6 $10.13 7/15/2020230,000 shares $2.21 million +12.1%3.5%3.6 $9.60 6/30/2020205,200 shares $2.27 million +316.2%3.1%3.2 $11.08 6/15/202049,300 shares $530.47 thousand +31.1%0.8%1 $10.76 ATXI Short Interest - Frequently Asked Questions What is Avenue Therapeutics' current short interest? Short interest is the volume of Avenue Therapeutics shares that have been sold short but have not yet been closed out or covered. As of May 31st, traders have sold 55,600 shares of ATXI short. 2.76% of Avenue Therapeutics' shares are currently sold short. Learn More on Avenue Therapeutics' current short interest. What is a good short interest ratio for Avenue Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. ATXI shares currently have a short interest ratio of 10.0. Learn More on Avenue Therapeutics's short interest ratio. What is a good short interest percentage for Avenue Therapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 2.76% of Avenue Therapeutics' floating shares are currently sold short. Is Avenue Therapeutics' short interest increasing or decreasing? Avenue Therapeutics saw a drop in short interest in the month of May. As of May 31st, there was short interest totaling 55,600 shares, a drop of 5.4% from the previous total of 58,800 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Avenue Therapeutics' short interest compare to its competitors? 2.76% of Avenue Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Avenue Therapeutics: Spruce Biosciences, Inc. (0.08%), Scinai Immunotherapeutics Ltd. (0.15%), Entero Therapeutics, Inc. (26.55%), Aspira Women's Health Inc. (1.19%), Vaccinex, Inc. (0.17%), Conduit Pharmaceuticals Inc. (7.85%), Protagenic Therapeutics, Inc. (5.97%), Windtree Therapeutics, Inc. (24.31%), Shuttle Pharmaceuticals Holdings, Inc. (5.15%), Akanda Corp. (0.70%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($64.96 billion), Invesco QQQ ($27.88 billion), iShares Russell 2000 ETF ($19.94 billion), iShares 20+ Year Treasury Bond ETF ($9.69 billion), Strategy Incorporated ($8.58 billion), SPDR S&P Biotech ETF ($5.72 billion), Invesco S&P 500 Equal Weight ETF ($5.45 billion), iShares iBoxx $ Investment Grade Corporate Bond ETF ($4.70 billion), Charter Communications, Inc. ($4.54 billion), and Industrial Select Sector SPDR Fund ($4.49 billion). View all of the most shorted stocks. What does it mean to sell short Avenue Therapeutics stock? Short selling ATXI is an investing strategy that aims to generate trading profit from Avenue Therapeutics as its price is falling. ATXI shares are trading down $0.05 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Avenue Therapeutics? A short squeeze for Avenue Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of ATXI, which in turn drives the price of the stock up even further. How often is Avenue Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ATXI, twice per month. The most recent reporting period available is May, 31 2025. More Short Interest Resources from MarketBeat Related Companies SPRB Short Squeeze SCNI Short Squeeze ENTO Short Squeeze AWH Short Squeeze VCNX Short Squeeze CDT Short Squeeze PTIX Short Squeeze WINT Short Squeeze SHPH Short Squeeze AKAN Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:ATXI) was last updated on 6/13/2025 by MarketBeat.com Staff From Our PartnersElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredWe’ve Entered the Most Bullish Phase of the CycleIt happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | SponsoredCollect $7k per month from Tesla’s SECRET dividendI just uncovered a strategy that could pay out up to $7,013 every month—without needing a traditional dividend...Investors Alley | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Avenue Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Avenue Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy ATXI Stock Free ATXI Stock Alerts